Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Certain Chinese herbs, especially Cacumen platycladi, can promote hair regrowth and reduce hair loss-related hormone levels in mice.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Anti-aging treatments like hair transplants, minoxidil, and finasteride effectively promote hair growth.

Collagen networks play a key role in hair loss and follicle miniaturization.

Nutritional interventions can help restore balance in male health by targeting oxidative stress and hormonal issues.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Low-level light therapy, possibly combined with other treatments, may become a leading hair loss treatment, while hirsutism often worsens with age and lacks preventive options.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Left-handed men experience more sexual side effects from finasteride treatment.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

PCOS has many symptoms, with high androgen levels being the most common.

Spironolactone is effective and safe for treating hair loss, excessive hair growth, and acne.

Hormones significantly affect skin health, with vitamin D playing a key role.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.